European Journal of Cancer
Volume 38, Issue 10 , Pages 1348-1350, July 2002

Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme

Department of Medicine, Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94815 Villejuif, France

Received 23 January 2002; accepted 25 January 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(02)00070-9

European Journal of Cancer
Volume 38, Issue 10 , Pages 1348-1350, July 2002

Article Tools

* Image Usage & Resolution